Resources

Findings show Parkinson’s disease risk is reduced in patients with type 2 diabetes mellitus (T2DM) after treatment with exenatide.

Researchers continue to uncover the many ways uncontrolled hyperglycemia can damage the body.

Empagliflozin significantly lowered LVMi, systolic blood pressure, and diastolic blood pressure in patients with CAD and type 2 diabetes.

A diabetes patient’s risk for chronic kidney disease or cardiovascular disease can be impacted by various factors, including ethnic background. 

Metformin use was associated with lower inflammatory markers before surgery, leading to improved outcomes post-surgery.

American Diabetes Association guidelines recommend that combination therapy be started in patients with unachieved glycemic control within three months. 

Just one lifestyle modification can go a long way.

Researchers say static electromagnetic fields (EMFs) could be a non-invasive and safe way of managing blood glucose.

A new study shows that resolving iron deficiency and or vitamin B12 deficiency anemia may affect A1c levels.  One of the most common tools used to screen for and evaluate a person’s control of diabetes is a glycated hemoglobin (A1c) test. An A1c test is advantageous because it reflects a patient’s …

By Sheri Colberg, PhD
In the past, most elite athletes attempted to improve performance through strategies to achieve "high CHO availability," meaning building up adequate pre-exercise glycogen levels and carbohydrate intake during the competition to meet fuel needs, but more recently many have aimed instead for a strategy called "low CHO availability."